Medical - Instruments & Supplies
Compare Stocks
5 / 10Stock Comparison
STSS vs NNBR vs SMPL vs MMSI vs NVCR
Revenue, margins, valuation, and 5-year total return — side by side.
Conglomerates
Packaged Foods
Medical - Instruments & Supplies
Medical - Instruments & Supplies
STSS vs NNBR vs SMPL vs MMSI vs NVCR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Instruments & Supplies | Conglomerates | Packaged Foods | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $8K | $139M | $1.24B | $3.72B | $1.92B |
| Revenue (TTM) | $223K | $435M | $1.45B | $1.54B | $674M |
| Net Income (TTM) | $-723K | $-35M | $91M | $139M | $-173M |
| Gross Margin | -7.6% | 2.3% | 34.0% | 48.7% | 75.2% |
| Operating Margin | -40.9% | -3.3% | 14.4% | 12.2% | -27.2% |
| Forward P/E | — | 42.0x | 7.4x | 15.1x | — |
| Total Debt | $4M | $211M | $304M | $898M | $290M |
| Cash & Equiv. | $864K | $11M | $98M | $449M | $103M |
STSS vs NNBR vs SMPL vs MMSI vs NVCR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 22 | May 26 | Return |
|---|---|---|---|
| Sharps Technology, … (STSS) | 100 | 0.0 | -100.0% |
| NN, Inc. (NNBR) | 100 | 92.4 | -7.6% |
| The Simply Good Foo… (SMPL) | 100 | 29.4 | -70.6% |
| Merit Medical Syste… (MMSI) | 100 | 98.8 | -1.2% |
| NovoCure Limited (NVCR) | 100 | 23.4 | -76.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: STSS vs NNBR vs SMPL vs MMSI vs NVCR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
STSS ranks third and is worth considering specifically for growth.
- 99.1% revenue growth vs NNBR's -9.1%
NNBR is the clearest fit if your priority is momentum.
- +50.8% vs SMPL's -64.8%
SMPL has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.
- beta 0.38
- Lower volatility, beta 0.38, Low D/E 16.8%, current ratio 3.64x
- Beta 0.38, current ratio 3.64x
- Better valuation composite
MMSI is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 11.7%, EPS growth 4.9%, 3Y rev CAGR 9.6%
- 214.6% 10Y total return vs NVCR's 30.3%
- 9.0% margin vs STSS's -324.8%
- 5.2% ROA vs NVCR's -16.5%, ROIC 7.2% vs -16.4%
Among these 5 stocks, NVCR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 99.1% revenue growth vs NNBR's -9.1% | |
| Value | Better valuation composite | |
| Quality / Margins | 9.0% margin vs STSS's -324.8% | |
| Stability / Safety | Beta 0.38 vs STSS's 2.56, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +50.8% vs SMPL's -64.8% | |
| Efficiency (ROA) | 5.2% ROA vs NVCR's -16.5%, ROIC 7.2% vs -16.4% |
STSS vs NNBR vs SMPL vs MMSI vs NVCR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
STSS vs NNBR vs SMPL vs MMSI vs NVCR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SMPL leads in 1 of 6 categories
MMSI leads 1 • NNBR leads 1 • STSS leads 0 • NVCR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MMSI and NVCR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MMSI is the larger business by revenue, generating $1.5B annually — 6924.7x STSS's $222,722. MMSI is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to STSS's -3.2%. On growth, NVCR holds the edge at +12.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $222,722 | $435M | $1.4B | $1.5B | $674M |
| EBITDAEarnings before interest/tax | -$8M | $22M | $231M | $290M | -$165M |
| Net IncomeAfter-tax profit | -$723,347 | -$35M | $91M | $139M | -$173M |
| Free Cash FlowCash after capex | -$10M | -$1M | $174M | $274M | -$48M |
| Gross MarginGross profit ÷ Revenue | -7.6% | +2.3% | +34.0% | +48.7% | +75.2% |
| Operating MarginEBIT ÷ Revenue | -40.9% | -3.3% | +14.4% | +12.2% | -27.2% |
| Net MarginNet income ÷ Revenue | -3.2% | -8.0% | +6.3% | +9.0% | -25.7% |
| FCF MarginFCF ÷ Revenue | -44.2% | -0.3% | +12.0% | +17.8% | -7.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +12.1% | -0.3% | +7.8% | +12.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +111.0% | -8.7% | -31.6% | +38.8% | -100.0% |
Valuation Metrics
SMPL leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 12.2x trailing earnings, SMPL trades at a 58% valuation discount to MMSI's 29.3x P/E. On an enterprise value basis, SMPL's 6.0x EV/EBITDA is more attractive than NNBR's 19.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7,830 | $139M | $1.2B | $3.7B | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $3M | $338M | $1.4B | $4.2B | $2.1B |
| Trailing P/EPrice ÷ TTM EPS | -0.00x | -2.58x | 12.20x | 29.26x | -13.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 41.98x | 7.39x | 15.05x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.51x | — | — |
| EV / EBITDAEnterprise value multiple | — | 19.03x | 5.97x | 13.06x | — |
| Price / SalesMarket cap ÷ Revenue | — | 0.33x | 0.86x | 2.45x | 2.92x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.93x | 0.70x | 2.38x | 5.51x |
| Price / FCFMarket cap ÷ FCF | — | 19.16x | 7.86x | 17.24x | — |
Profitability & Efficiency
MMSI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MMSI delivers a 8.9% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-51 for NVCR. SMPL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to STSS's 1.89x. On the Piotroski fundamental quality scale (0–9), MMSI scores 6/9 vs NNBR's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.0% | -28.4% | +5.2% | +8.9% | -50.8% |
| ROA (TTM)Return on assets | -4.2% | -7.7% | +3.7% | +5.2% | -16.5% |
| ROICReturn on invested capital | -120.0% | -4.5% | +8.1% | +7.2% | -16.4% |
| ROCEReturn on capital employed | -153.7% | -5.0% | +9.4% | +7.9% | -28.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.89x | 1.44x | 0.17x | 0.57x | 0.85x |
| Net DebtTotal debt minus cash | $3M | $200M | $206M | $450M | $187M |
| Cash & Equiv.Liquid assets | $864,041 | $11M | $98M | $449M | $103M |
| Total DebtShort + long-term debt | $4M | $211M | $304M | $898M | $290M |
| Interest CoverageEBIT ÷ Interest expense | -0.20x | -0.74x | 6.77x | 10.74x | -96.80x |
Total Returns (Dividends Reinvested)
NNBR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MMSI five years ago would be worth $9,644 today (with dividends reinvested), compared to $1 for STSS. Over the past 12 months, NNBR leads with a +50.8% total return vs SMPL's -64.8%. The 3-year compound annual growth rate (CAGR) favors NNBR at 40.7% vs STSS's -92.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.5% | +106.0% | -36.4% | -27.9% | +28.3% |
| 1-Year ReturnPast 12 months | -59.9% | +50.8% | -64.8% | -33.8% | +1.1% |
| 3-Year ReturnCumulative with dividends | -100.0% | +178.4% | -67.8% | -26.5% | -75.7% |
| 5-Year ReturnCumulative with dividends | -100.0% | -63.4% | -64.3% | -3.6% | -91.3% |
| 10-Year ReturnCumulative with dividends | -100.0% | -75.7% | +3.7% | +214.6% | +30.3% |
| CAGR (3Y)Annualised 3-year return | -92.9% | +40.7% | -31.5% | -9.8% | -37.6% |
Risk & Volatility
Evenly matched — NNBR and SMPL each lead in 1 of 2 comparable metrics.
Risk & Volatility
SMPL is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than STSS's 2.56 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NNBR currently trades 92.3% from its 52-week high vs STSS's 10.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.66x | 2.01x | 0.34x | 0.66x | 2.15x |
| 52-Week HighHighest price in past year | $18.23 | $2.99 | $36.92 | $100.19 | $20.06 |
| 52-Week LowLowest price in past year | $1.42 | $1.10 | $10.21 | $59.74 | $9.82 |
| % of 52W HighCurrent price vs 52-week peak | +10.3% | +92.3% | +33.7% | +62.2% | +83.9% |
| RSI (14)Momentum oscillator 0–100 | 55.6 | 65.6 | 42.9 | 34.9 | 69.8 |
| Avg Volume (50D)Average daily shares traded | 327K | 936K | 2.8M | 769K | 1.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: NNBR as "Buy", SMPL as "Buy", MMSI as "Buy", NVCR as "Buy". Consensus price targets imply 99.0% upside for NVCR (target: $34) vs 47.3% for SMPL (target: $18).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $18.33 | $95.00 | $33.50 |
| # AnalystsCovering analysts | — | 9 | 24 | 14 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +4.1% | 0.0% | 0.0% |
SMPL leads in 1 of 6 categories (Valuation Metrics). MMSI leads in 1 (Profitability & Efficiency). 2 tied.
STSS vs NNBR vs SMPL vs MMSI vs NVCR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is STSS or NNBR or SMPL or MMSI or NVCR a better buy right now?
For growth investors, Merit Medical Systems, Inc.
(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus -9. 1% for NN, Inc. (NNBR). The Simply Good Foods Company (SMPL) offers the better valuation at 12. 2x trailing P/E (7. 4x forward), making it the more compelling value choice. Analysts rate NN, Inc. (NNBR) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — STSS or NNBR or SMPL or MMSI or NVCR?
On trailing P/E, The Simply Good Foods Company (SMPL) is the cheapest at 12.
2x versus Merit Medical Systems, Inc. at 29. 3x. On forward P/E, The Simply Good Foods Company is actually cheaper at 7. 4x.
03Which is the better long-term investment — STSS or NNBR or SMPL or MMSI or NVCR?
Over the past 5 years, Merit Medical Systems, Inc.
(MMSI) delivered a total return of -3. 6%, compared to -100. 0% for Sharps Technology, Inc. (STSS). Over 10 years, the gap is even starker: MMSI returned +209. 3% versus STSS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — STSS or NNBR or SMPL or MMSI or NVCR?
By beta (market sensitivity over 5 years), The Simply Good Foods Company (SMPL) is the lower-risk stock at 0.
34β versus Sharps Technology, Inc. 's 2. 66β — meaning STSS is approximately 677% more volatile than SMPL relative to the S&P 500. On balance sheet safety, The Simply Good Foods Company (SMPL) carries a lower debt/equity ratio of 17% versus 189% for Sharps Technology, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — STSS or NNBR or SMPL or MMSI or NVCR?
By revenue growth (latest reported year), Merit Medical Systems, Inc.
(MMSI) is pulling ahead at 11. 7% versus -9. 1% for NN, Inc. (NNBR). On earnings-per-share growth, the picture is similar: NovoCure Limited grew EPS 21. 8% year-over-year, compared to -782. 0% for Sharps Technology, Inc.. Over a 3-year CAGR, MMSI leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — STSS or NNBR or SMPL or MMSI or NVCR?
Merit Medical Systems, Inc.
(MMSI) is the more profitable company, earning 8. 5% net margin versus -324. 8% for Sharps Technology, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMPL leads at 15. 1% versus -40. 9% for STSS. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is STSS or NNBR or SMPL or MMSI or NVCR more undervalued right now?
On forward earnings alone, The Simply Good Foods Company (SMPL) trades at 7.
4x forward P/E versus 42. 0x for NN, Inc. — 34. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVCR: 99. 0% to $33. 50.
08Which pays a better dividend — STSS or NNBR or SMPL or MMSI or NVCR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is STSS or NNBR or SMPL or MMSI or NVCR better for a retirement portfolio?
For long-horizon retirement investors, The Simply Good Foods Company (SMPL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
34)). Sharps Technology, Inc. (STSS) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SMPL: +2. 2%, STSS: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between STSS and NNBR and SMPL and MMSI and NVCR?
These companies operate in different sectors (STSS (Healthcare) and NNBR (Industrials) and SMPL (Consumer Defensive) and MMSI (Healthcare) and NVCR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: STSS is a small-cap quality compounder stock; NNBR is a small-cap quality compounder stock; SMPL is a small-cap deep-value stock; MMSI is a small-cap quality compounder stock; NVCR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.